List of Tables
Table 1. Global Neurorehabilitation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Brain Injury
Table 3. Key Players of Spinal Cord Injury
Table 4. Key Players of Peripheral Nerve Injury
Table 5. Key Players of Other
Table 6. Global Neurorehabilitation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Neurorehabilitation Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neurorehabilitation Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Neurorehabilitation Therapy Market Share by Region (2020-2025)
Table 10. Global Neurorehabilitation Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Neurorehabilitation Therapy Market Share by Region (2026-2031)
Table 12. Neurorehabilitation Therapy Market Trends
Table 13. Neurorehabilitation Therapy Market Drivers
Table 14. Neurorehabilitation Therapy Market Challenges
Table 15. Neurorehabilitation Therapy Market Restraints
Table 16. Global Neurorehabilitation Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Neurorehabilitation Therapy Market Share by Players (2020-2025)
Table 18. Global Top Neurorehabilitation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation Therapy as of 2024)
Table 19. Ranking of Global Top Neurorehabilitation Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Neurorehabilitation Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Neurorehabilitation Therapy, Headquarters and Area Served
Table 22. Global Key Players of Neurorehabilitation Therapy, Product and Application
Table 23. Global Key Players of Neurorehabilitation Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurorehabilitation Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Neurorehabilitation Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Neurorehabilitation Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Neurorehabilitation Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Neurorehabilitation Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Neurorehabilitation Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Neurorehabilitation Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Neurorehabilitation Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Neurorehabilitation Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. VISHEE Company Details
Table 49. VISHEE Business Overview
Table 50. VISHEE Neurorehabilitation Therapy Product
Table 51. VISHEE Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 52. VISHEE Recent Development
Table 53. Beijing Bo'ai Hospital Company Details
Table 54. Beijing Bo'ai Hospital Business Overview
Table 55. Beijing Bo'ai Hospital Neurorehabilitation Therapy Product
Table 56. Beijing Bo'ai Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 57. Beijing Bo'ai Hospital Recent Development
Table 58. Beijing Rehabilitation Hospital of Capital Medical University Company Details
Table 59. Beijing Rehabilitation Hospital of Capital Medical University Business Overview
Table 60. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product
Table 61. Beijing Rehabilitation Hospital of Capital Medical University Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 62. Beijing Rehabilitation Hospital of Capital Medical University Recent Development
Table 63. NCC Company Details
Table 64. NCC Business Overview
Table 65. NCC Neurorehabilitation Therapy Product
Table 66. NCC Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 67. NCC Recent Development
Table 68. CHIEFTAIN Company Details
Table 69. CHIEFTAIN Business Overview
Table 70. CHIEFTAIN Neurorehabilitation Therapy Product
Table 71. CHIEFTAIN Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 72. CHIEFTAIN Recent Development
Table 73. Tongji Hospital Company Details
Table 74. Tongji Hospital Business Overview
Table 75. Tongji Hospital Neurorehabilitation Therapy Product
Table 76. Tongji Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 77. Tongji Hospital Recent Development
Table 78. Haobro Medical Device Company Details
Table 79. Haobro Medical Device Business Overview
Table 80. Haobro Medical Device Neurorehabilitation Therapy Product
Table 81. Haobro Medical Device Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 82. Haobro Medical Device Recent Development
Table 83. DIH Company Details
Table 84. DIH Business Overview
Table 85. DIH Neurorehabilitation Therapy Product
Table 86. DIH Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 87. DIH Recent Development
Table 88. Sun Java Company Details
Table 89. Sun Java Business Overview
Table 90. Sun Java Neurorehabilitation Therapy Product
Table 91. Sun Java Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 92. Sun Java Recent Development
Table 93. Aoyang Health Company Details
Table 94. Aoyang Health Business Overview
Table 95. Aoyang Health Neurorehabilitation Therapy Product
Table 96. Aoyang Health Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 97. Aoyang Health Recent Development
Table 98. PKUCare Rehabilitation Hospital Company Details
Table 99. PKUCare Rehabilitation Hospital Business Overview
Table 100. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product
Table 101. PKUCare Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 102. PKUCare Rehabilitation Hospital Recent Development
Table 103. Beijing Puhua International Hospital Company Details
Table 104. Beijing Puhua International Hospital Business Overview
Table 105. Beijing Puhua International Hospital Neurorehabilitation Therapy Product
Table 106. Beijing Puhua International Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 107. Beijing Puhua International Hospital Recent Development
Table 108. Xiangyu Medical Company Details
Table 109. Xiangyu Medical Business Overview
Table 110. Xiangyu Medical Neurorehabilitation Therapy Product
Table 111. Xiangyu Medical Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 112. Xiangyu Medical Recent Development
Table 113. Beijing United Family Rehabilitation Hospital Company Details
Table 114. Beijing United Family Rehabilitation Hospital Business Overview
Table 115. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product
Table 116. Beijing United Family Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 117. Beijing United Family Rehabilitation Hospital Recent Development
Table 118. Bionik Laboratories Corp Company Details
Table 119. Bionik Laboratories Corp Business Overview
Table 120. Bionik Laboratories Corp Neurorehabilitation Therapy Product
Table 121. Bionik Laboratories Corp Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 122. Bionik Laboratories Corp Recent Development
Table 123. BioScience Managers Ltd Company Details
Table 124. BioScience Managers Ltd Business Overview
Table 125. BioScience Managers Ltd Neurorehabilitation Therapy Product
Table 126. BioScience Managers Ltd Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 127. BioScience Managers Ltd Recent Development
Table 128. Bioventus Company Details
Table 129. Bioventus Business Overview
Table 130. Bioventus Neurorehabilitation Therapy Product
Table 131. Bioventus Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 132. Bioventus Recent Development
Table 133. DIH (Hocoma AG) Company Details
Table 134. DIH (Hocoma AG) Business Overview
Table 135. DIH (Hocoma AG) Neurorehabilitation Therapy Product
Table 136. DIH (Hocoma AG) Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 137. DIH (Hocoma AG) Recent Development
Table 138. Ekso Bionics Holdings Company Details
Table 139. Ekso Bionics Holdings Business Overview
Table 140. Ekso Bionics Holdings Neurorehabilitation Therapy Product
Table 141. Ekso Bionics Holdings Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 142. Ekso Bionics Holdings Recent Development
Table 143. Eodyne Company Details
Table 144. Eodyne Business Overview
Table 145. Eodyne Neurorehabilitation Therapy Product
Table 146. Eodyne Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 147. Eodyne Recent Development
Table 148. Neofect Company Details
Table 149. Neofect Business Overview
Table 150. Neofect Neurorehabilitation Therapy Product
Table 151. Neofect Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 152. Neofect Recent Development
Table 153. Neuro Rehab VR Company Details
Table 154. Neuro Rehab VR Business Overview
Table 155. Neuro Rehab VR Neurorehabilitation Therapy Product
Table 156. Neuro Rehab VR Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 157. Neuro Rehab VR Recent Development
Table 158. Reha Technology AG Company Details
Table 159. Reha Technology AG Business Overview
Table 160. Reha Technology AG Neurorehabilitation Therapy Product
Table 161. Reha Technology AG Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
Table 162. Reha Technology AG Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Neurorehabilitation Therapy Picture
Figure 2. Global Neurorehabilitation Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neurorehabilitation Therapy Market Share by Type: 2024 VS 2031
Figure 4. Brain Injury Features
Figure 5. Spinal Cord Injury Features
Figure 6. Peripheral Nerve Injury Features
Figure 7. Other Features
Figure 8. Global Neurorehabilitation Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Neurorehabilitation Therapy Market Share by Application: 2024 VS 2031
Figure 10. General Hospital Case Studies
Figure 11. Rehabilitation Specialist Hospital Case Studies
Figure 12. Community Rehabilitation Center Case Studies
Figure 13. Neurorehabilitation Therapy Report Years Considered
Figure 14. Global Neurorehabilitation Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Neurorehabilitation Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Neurorehabilitation Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Neurorehabilitation Therapy Market Share by Players in 2024
Figure 18. Global Top Neurorehabilitation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Neurorehabilitation Therapy Revenue in 2024
Figure 20. North America Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Neurorehabilitation Therapy Market Share by Country (2020-2031)
Figure 22. United States Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Neurorehabilitation Therapy Market Share by Country (2020-2031)
Figure 26. Germany Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Neurorehabilitation Therapy Market Share by Region (2020-2031)
Figure 34. China Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Neurorehabilitation Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Neurorehabilitation Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. VISHEE Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 50. Beijing Bo'ai Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 51. Beijing Rehabilitation Hospital of Capital Medical University Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 52. NCC Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 53. CHIEFTAIN Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 54. Tongji Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 55. Haobro Medical Device Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 56. DIH Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 57. Sun Java Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 58. Aoyang Health Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 59. PKUCare Rehabilitation Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 60. Beijing Puhua International Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 61. Xiangyu Medical Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 62. Beijing United Family Rehabilitation Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 63. Bionik Laboratories Corp Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 64. BioScience Managers Ltd Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 65. Bioventus Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 66. DIH (Hocoma AG) Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 67. Ekso Bionics Holdings Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 68. Eodyne Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 69. Neofect Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 70. Neuro Rehab VR Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 71. Reha Technology AG Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed